Complications Associated With Use of the Wolverine Cutting Balloon: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database
Journal of Invasive Cardiology · 2025
DOI: 10.25270/jic/24.00300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Invasive Cardiology, 2025. Verfasst von Aaron Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Email: alee10@pennstatehealth.psu.edu. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Equipment Failure, Intraoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
OBJECTIVES: The Wolverine cutting balloon (CB) (Boston Scientific) is a specialized balloon catheter with microsurgical blades that is used for balloon-resistant lesions. The Manufacturer and User Facility Device Experience (MAUDE) database serves as a repository for reports of medical device complications. The aim of this study was to analyze complications associated with CB use during percutaneous coronary intervention in real-world contemporary practice. METHODS: The MAUDE database was searched from January 1, 2020 through December 31, 2023 for reports of complications associated with CB use. Data from individual reports were extracted for analysis. RESULTS: The final analysis included 2278 complications, of which 97.3% (n = 2216) were associated with device malfunction, 2.4% (n = 55) were associated with patient injury, and 0.3% (n = 7) were associated with patient death. The most common complication overall was balloon rupture (n = 1847), while the most common complication associated with patient injury or death was device entrapment (n = 33). The median number of inflations was significantly higher for complications associated with patient injury or death (3 [IQR 1-8]) compared with complications associated with device malfunction (1[IQR 1-2]) (P = .0035). The median maximum inflation pressure was significantly higher for complications associated with patient injury or death (12 [IQR 11-15] atm) compared with complications associated with device malfunction (8 [IQR 6-10] atm) (P = .0001). CONCLUSIONS: Overall, 2.7% of reported complications were associated with patient injury or death. The most common complication overall was balloon rupture. Device entrapment was the most common complication among reports associated with patient injury or death. Higher inflation pressures and greater number of inflations may be associated with adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Email: alee10@pennstatehealth.psu.edu.
- Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
- WellSpan Good Samaritan Hospital, Lebanon, Pennsylvania.
- Cook County Health, Chicago, Illinois.
- Northwestern Memorial Hospital, Chicago, Illinois.
Zitieren
APA
Lee, A., Jung, D., Ahmed, M., Norton, J., Kaleta, F., Muallem, S., Patel, M., Mathur, M., Kozak, M., Gilchrist, I. C., & Zack, C. J. (2025). Complications Associated With Use of the Wolverine Cutting Balloon: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database. Journal of Invasive Cardiology. https://doi.org/10.25270/jic/24.00300
Vancouver
Lee A, Jung D, Ahmed M, Norton J, Kaleta F, Muallem S, et al. Complications Associated With Use of the Wolverine Cutting Balloon: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database. Journal of Invasive Cardiology. 2025. doi:10.25270/jic/24.00300
BibTeX
@article{Lee2025,
author = {Lee, Aaron and Jung, Dorothy and Ahmed, Mohammad and Norton, Jonathan and Kaleta, Francois and Muallem, Samer and Patel, Maulin and Mathur, Moses and Kozak, Mark and Gilchrist, Ian C and Zack, Chad J},
title = {Complications Associated With Use of the Wolverine Cutting Balloon: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database},
journal = {Journal of Invasive Cardiology},
year = {2025},
doi = {10.25270/jic/24.00300}
}
EUVIMED